Economiic Home Method Watch Market RSI Search

NextCure, Inc. NXTC

Sector:

Healthcare

Industry:

Biotechnology

Description:

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NextCure, Inc. website

Recent Quarter:

2024-11-07

Upcoming Quarter:

2025-03-20

Annual Reports

Date2024-03-21
Revenue 0
Net Income -62,723,000
EPS -2.25
Basic Shares 27,836,000
Diluted Shares 27,836,584
Report Link
Date2023-03-02
Revenue 0
Net Income -69,433,000
EPS -2.5
Basic Shares 27,744,209
Diluted Shares 27,744,209
Report Link
Date2022-03-03
Revenue 0
Net Income -69,389,000
EPS -2.51
Basic Shares 27,615,977
Diluted Shares 27,615,977
Report Link
Date2021-03-04
Revenue 22,378,000
Net Income -33,190,000
EPS -1.21
Basic Shares 27,532,177
Diluted Shares 27,532,177
Report Link
Date2020-03-12
Revenue 6,347,000
Net Income -33,737,000
EPS -2.15
Basic Shares 15,695,461
Diluted Shares 15,695,461
Report Link
Date2018-12-31
Revenue 0
Net Income -22,799,000
EPS -2.27
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link
Date2017-12-31
Revenue 0
Net Income -15,469,000
EPS -1.54
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link

Annual Ratios

Date2023-12-31
PE -0.51
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -2.39
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -9.04
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -26.21
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -8.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -12.91
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-07
Revenue 0
Net Income -11,540,000
EPS -0.41
Basic Shares 27,975,840
Diluted Shares 27,975,840
Report Link
Date2024-08-01
Revenue 0
Net Income -15,404,000
EPS -0.55
Basic Shares 27,972,744
Diluted Shares 27,972,744
Report Link
Date2024-05-02
Revenue 0
Net Income -17,107,000
EPS -0.61
Basic Shares 27,903,040
Diluted Shares 27,903,040
Report Link
Date2024-03-21
Revenue 6,284,000
Net Income -14,467,000
EPS -0.52
Basic Shares 27,909,980
Diluted Shares 27,909,980
Report Link
Date2023-11-02
Revenue 0
Net Income -14,301,000
EPS -0.51
Basic Shares 27,839,968
Diluted Shares 27,839,968
Report Link
Date2023-08-03
Revenue 0
Net Income -17,859,000
EPS -0.64
Basic Shares 27,828,741
Diluted Shares 27,828,741
Report Link
Date2023-05-04
Revenue 0
Net Income -15,121,000
EPS -0.54
Basic Shares 27,774,536
Diluted Shares 27,774,536
Report Link
Date2023-03-02
Revenue 0
Net Income -16,829,000
EPS -0.61
Basic Shares 27,774,536
Diluted Shares 27,774,536
Report Link
Date2022-11-03
Revenue 0
Net Income -18,583,000
EPS -0.67
Basic Shares 27,748,844
Diluted Shares 27,748,844
Report Link
Date2022-08-04
Revenue 0
Net Income -17,713,000
EPS -0.64
Basic Shares 27,744,762
Diluted Shares 27,744,762
Report Link
Date2022-05-05
Revenue 0
Net Income -20,433,000
EPS -0.74
Basic Shares 27,708,768
Diluted Shares 27,708,768
Report Link
Date2022-03-03
Revenue 0
Net Income -16,939,000
EPS -0.61
Basic Shares 27,615,038
Diluted Shares 27,615,038
Report Link
Date2021-11-04
Revenue 0
Net Income -17,930,000
EPS -0.65
Basic Shares 27,615,038
Diluted Shares 27,615,038
Report Link
Date2021-08-05
Revenue 0
Net Income -17,987,000
EPS -0.65
Basic Shares 27,610,398
Diluted Shares 27,610,398
Report Link
Date2021-05-06
Revenue 0
Net Income -16,533,000
EPS -0.6
Basic Shares 27,597,426
Diluted Shares 27,597,426
Report Link
Date2021-03-04
Revenue 0.000,022,377,999,999,999,998
Net Income -15,461,000
EPS -0.56
Basic Shares 27,547,737
Diluted Shares 27,547,737
Report Link
Date2020-11-05
Revenue 0
Net Income -16,367,000
EPS -0.59
Basic Shares 27,547,737
Diluted Shares 27,547,737
Report Link
Date2020-08-06
Revenue 0
Net Income -14,508,000
EPS -0.53
Basic Shares 27,518,129
Diluted Shares 27,518,129
Report Link
Date2020-05-07
Revenue 22,378,000
Net Income 9,733,000
EPS 0.35
Basic Shares 27,506,927
Diluted Shares 29,348,615
Report Link
Date2020-03-12
Revenue 2,005,000
Net Income -10,927,000
EPS -0.4
Basic Shares 27,499,260
Diluted Shares 27,506,927
Report Link
Date2019-11-12
Revenue 1,583,000
Net Income -8,434,000
EPS -0.37
Basic Shares 22,715,567
Diluted Shares 22,715,567
Report Link
Date2019-08-12
Revenue 1,402,000
Net Income -8,221,000
EPS -0.61
Basic Shares 13,498,393
Diluted Shares 13,498,393
Report Link
Date2019-06-10
Revenue 1,357,000
Net Income -6,155,000
EPS -0.28
Basic Shares 21,935,381
Diluted Shares 21,935,381
Report Link
Date2018-12-31
Revenue 0
Net Income -6,862,000
EPS -0.68
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link
Date2018-09-30
Revenue 0
Net Income -5,710,000
EPS -0.57
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link
Date2018-06-30
Revenue 0
Net Income -5,231,000
EPS -0.52
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link
Date2018-03-31
Revenue 0
Net Income -4,996,000
EPS -0.5
Basic Shares 10,038,582
Diluted Shares 10,038,582
Report Link

Quarterly Ratios

Date2024-09-30
PE -0.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -0.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -0.55
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -0.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -0.70
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -0.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -1.03
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -1.84
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -1.65
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -2.45
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -2.60
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -3.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -4.18
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -4.86
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -3.70
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -10.17
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE 26.19
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -35.44
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -20.77
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -7.25
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE -17.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -7.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-09-30
PE -8.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -9.55
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE -10.00
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

40.49

Price:

$1.30

Market Cap:

36,408,710

EPS TTM:

-2.09

PE Ratio:

-0.62

PEPSG:

1.3553

Fwd PE:

-0.84

Volume:

35,700

2 Year Price Change

0.878

Index 2 Year Price Change

1.497

5 Year Price Change

0.036

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: